Newsletters Conference Subscribe
Coverage

Hematology

Hematology coverage from APO|APE News.

 Hematology

International LGLL Consortium Publishes Consensus Criteria for Diagnosis, Treatment Initiation and Response Assessment in T-LGL Leukemia

August 26, 2026
 Hematology

DNA Methylation Epitypes Sort 1,262 De Novo AML Patients and Catch Mutation Mimics That Genetic Testing Misses

August 26, 2026
 Hematology

FDA Approves Orca Bio's Donor-Derived Regulatory T Cell Therapy Tregzi for Matched-Donor Transplant in Blood Cancers

August 22, 2026
 Hematology

European Commission Approves Johnson & Johnson's Teclistamab With Daratumumab for Relapsed or Refractory Multiple Myeloma

August 22, 2026
 Hematology

Gilteritinib, Venetoclax and Azacitidine Produce 60.5 Percent Composite Remission in Relapsed FLT3-Mutated AML

August 20, 2026
 Hematology

City of Hope and PeproMene Bio Report BAFF-R CAR T-Cell Therapy in Relapsed B-Cell Lymphomas

August 20, 2026
 Hematology

Hematogenix Flow Cytometry Assay Named in the Label Behind the Accelerated Approval of Zenbexus

August 19, 2026
 Hematology

Off-the-Shelf Base-Edited CAR33 T Cells Miss Primary Endpoints in First-in-Human AML Trial

August 19, 2026
 Hematology

A 77-Year-Old Woman Met the Lupus Criteria and Turned Out to Have Primary Splenic Diffuse Large B-Cell Lymphoma

August 18, 2026
 Hematology

End-of-Consolidation MRD Predicts Survival in Pediatric Core-Binding Factor AML, Taiwan Group Reports

August 18, 2026
 Hematology

BeOne Medicines and The Max Foundation Renew Donated BRUKINSA Program for CLL Through 2028

August 18, 2026
 Hematology

Flatiron Health Cohort of 482 AML Patients Finds Two-Month Real-World Event-Free Survival on FLT3, IDH1 and IDH2 Inhibitors, Whatever the Line of Therapy

August 17, 2026
 Hematology

Serum MALDI-TOF Mass Spectrometry Tracks Bone Marrow MRD Through Maintenance in 237 CASSIOPEIA Myeloma Patients, Blood Reports

August 17, 2026